Stephen Russell

Company: Vyriad, Inc.

Job title: Chief Executive Officer

Seminars:

Intravenous Administration of an Oncolytic Vesicular Stomatitis Virus: Clinical Experience to Date 9:00 am

Voyager V1 has been administered intravenously to over 100 cancer patients in clinical trials Compelling evidence of single agent activity after a single infusion will be presentedRead more

day: Day Two